Stock IPA IMMUNOPRECISE ANTIBODIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company ImmunoPrecise Antibodies Ltd. Toronto S.E.

Equities

IPA

CA45257F2008

Pharmaceuticals

Business Summary

ImmunoPrecise Antibodies Ltd. is a Canada-based biotherapeutic research and technology company. It leverages systems biology, multiomics modelling and artificial intelligence systems to support its technologies in bioplatform-based antibody discovery. Its services include highly specialized, full-continuum therapeutic biologics discovery, development, and out-licensing to support its business partners to discover and develop novel biologics. It utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases. It offers services, such as immunogen design and manufacturing, B cell sorting incorporating its function-first B cell screening and sequencing, and the production and screening of custom, immune, and naive phage display libraries. It also operates LSA instrument platform, which is a provider of high-throughput large and small molecule screening and characterization solutions.

Number of employees: 102

Sales per Business

USD in Million2022Weight2023Weight Delta
Antibody Production Project
90.4 %
14 89.6 % 14 90.4 % +1.56%
Antibody Production Product
8.5 %
1 8.5 % 1 8.5 % -0.20%
Cryostorage
1.2 %
0 1.8 % 0 1.2 % -36.11%

Sales per region

USD in Million2022Weight2023Weight Delta
Europe
45.7 %
8 48.7 % 7 45.7 % -5.42%
United States
45.3 %
5 35.2 % 7 45.3 % +29.67%
Australia
3.0 %
1 8.0 % 0 3.0 % -61.39%
Canada
3.0 %
0 3.0 % 0 3.0 % +1.96%
Other
2.9 %
1 5.2 % 0 2.9 % -43.58%

Managers

Managers TitleAgeSince
Jennifer Bath CEO
 Chief Executive Officer - 18-02-20
Kristin Taylor DFI
 Director of Finance/CFO - 23-09-28
Ilse Roodink CTO
 Chief Tech/Sci/R&D Officer - 21-06-30
Frederick Chabot IRC
 Investor Relations Contact - -
Barry Duplantis PRN
 Corporate Officer/Principal - -
Kari Graber PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Mitchell Levine CHM
 Chairman - -
Chris Buyse BRD
 Director/Board Member 59 23-09-04
Jennifer Bath CEO
 Chief Executive Officer - 18-02-20
Dirk Witters BRD
 Director/Board Member - 23-09-04
Barry Springer BRD
 Director/Board Member - 23-09-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 26,315,260 22,738,411 ( 86.41 %) 0 86.41 %

Shareholders

NameEquities%Valuation
Twee Charmquark
11.90 %
3,131,730 11.90 % 5 M $
Ingalls & Snyder LLC
5.008 %
1,317,819 5.008 % 2 M $
Ingalls & Snyder LLC
4.869 %
1,281,305 4.869 % 2 M $
Jennifer Bath
0.9455 %
248,818 0.9455 % 378 203 $
Citadel Securities GP LLC
0.2851 %
75,031 0.2851 % 114 047 $
Gregory Smith
0.2755 %
72,500 0.2755 % 110 200 $
Northern Trust Global Investments Ltd.
0.2315 %
60,914 0.2315 % 92 589 $
Squarepoint OPS LLC
0.1822 %
47,957 0.1822 % 72 895 $
BMO Bank NA (Investment Management)
0.1806 %
47,521 0.1806 % 72 232 $
CIBC World Markets, Inc.
0.1566 %
41,200 0.1566 % 62 624 $

Company contact information

ImmunoPrecise Antibodies Ltd.

4464 Markham Street Suite 3204

V8Z 7X8, Victoria

+250-483-0308

http://www.immunoprecise.com
address ImmunoPrecise Antibodies Ltd.(IPA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
CSL LIMITED Stock CSL Limited
-4.66% 86.13B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 39.82B
BIOGEN INC. Stock Biogen Inc.
-19.27% 30.42B
UCB Stock UCB
+57.86% 25.23B
INCYTE CORPORATION Stock Incyte Corporation
-17.69% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.00% 11.51B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.14% 11.95B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.24% 8.71B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-8.42% 8.12B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. IPA Stock
  4. IPA Stock
  5. Company ImmunoPrecise Antibodies Ltd.